Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprot

BE Groenemeyer, MD Hallman, PWA Reymer, E Gagne, JA Kuivenhoven, T de Bruin, H Jansen, KI Lie, AVG Bruschke, E Boerwinkle, R Hayden, JP Kastelein

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2628-2635
Number of pages8
Issue number12
Publication statusPublished - 1997
Externally publishedYes

Cite this